Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

46 citing papers in PubMed.

1. The Cardiovascular Intervention Improvement Telemedicine Study (CITIES): rationale for a tailored behavioral and educational pharmacist-administered intervention for achieving cardiovascular disease risk reduction.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2014
   Trial
2. Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.Cardiovascular ultrasound · 2011
   Trial
3. Achieving cholesterol targets by individualizing starting doses of statin according to baseline low-density lipoprotein cholesterol and coronary artery disease risk category: the CANadians Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (CanACTFAST) study.The Canadian journal of cardiology · 2010
   Trial
4. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study.Journal of general internal medicine · 2009
   Trial
5. Control of lipids at baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Preventive cardiology · 2009
   Trial
6. Surveillance and treatment of dyslipidemia in the post-infarct patient: can a nurse-led management approach make a difference?The Canadian journal of cardiology · 2006
   Trial
7. Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2006
   Trial
8. Evidence-based periodic health examination of adults. Memory aid for primary care physicians.Canadian family physician Medecin de famille canadien · 2006
   Trial
9. Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2000
   Trial
10. Knowledge and lifestyle modifications for dyslipidaemia among patients on statins in Pretoria.Journal of the colleges of medicine of South Africa · 2024
    Article
11. Cardiorespiratory fitness estimations and their ability to predict all-cause mortality in patients with cardiovascular disease.International journal of cardiology. Cardiovascular risk and prevention · 2022
    Article
12. Effect of nutrition education and traditional game-based physical activity interventions, on lipid profile improvement in overweight and obese children in West Java Indonesia.Nutrition research and practice · 2021
    Article
13. Dyslipidaemia for patients with low-energy femoral neck fractures after the treatment of cancellous screws: a retrospective study with a 3-year minimum follow-up.BMC musculoskeletal disorders · 2017
    Article
14. Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden.International journal of clinical practice · 2016
    Article
15. Are the new guidelines for the use of lipid-lowering agents sound, and should their adoption be encouraged?The Canadian journal of hospital pharmacy · 2014
    Article
16. Contemporary management and attainment of cholesterol targets for patients with dyslipidemia in China.PloS one · 2013
    Article
17. Extract of Wax Gourd Peel Prevents High-Fat Diet-Induced Hyperlipidemia in C57BL/6 Mice via the Inhibition of the PPARγ Pathway.Evidence-based complementary and alternative medicine : eCAM · 2013
    Article
18. Cardiovascular risk factor awareness in a disadvantaged inner-city population--implications for preventive strategies.The Canadian journal of cardiology · 2008
    Article
19. Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience.Vascular health and risk management · 2008
    Article
20. Missed opportunities for the secondary prevention of cardiovascular disease in Canada.The Canadian journal of cardiology · 2007
    Article

Corrections and comments

• Commented on by
  Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.2003

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as